Chlorambucil

Bone Marrow Suppression; Teratogen

• Bone Marrow Suppression: severe
• Carcinogen in humans
• Mutagen, Teratogen: Probable in humans
• Infertility associated with this drug

MONITORING RECOMMENDATIONS RELATED TO BLACK BOX DATA

• Perform weekly hematological testing to determine hemoglobin, total & differential leukocyte counts, & quantitative platelet counts. Perform WBC during the first 3 to 6 weeks of therapy, at 3 or 4 days after each weekly complete blood cell counts.

Patient Counseling Information

• Leukeran

Package Inserts

Chlorambucil

Additional Information

• PubMed - Chlorambucil